Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (15)

2023

  1. Expert opinion paper on the treatment of hemophilia a with emicizumab

    Hematology (Amsterdam, Netherlands), Vol. 28, Núm. 1, pp. 2166334

  2. Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project

    Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1

  3. Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain

    European Journal of Haematology, Vol. 111, Núm. 3, pp. 485-490

2021

  1. Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial

    Blood Cancer Journal, Vol. 11, Núm. 5

2018

  1. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

    Haematologica, Vol. 103, Núm. 1, pp. 148-162

2013

  1. Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does -7/7q- detection by FISH have prognostic value?

    Leukemia Research, Vol. 37, Núm. 4, pp. 416-421

2012

  1. The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome

    PLoS ONE, Vol. 7, Núm. 8

2011

  1. Cell-cycle distribution of different cell compartments in normal versus reactive bone marrow: A frame of reference for the study of dysplastic hematopoiesis

    Cytometry Part B - Clinical Cytometry, Vol. 80 B, Núm. 6, pp. 354-361

2010

  1. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era

    European Journal of Haematology, Vol. 85, Núm. 4, pp. 321-328

2009

  1. Identification of leptomeningeal disease in aggressive B-Cell non-Hodgkin's lymphoma: Improved sensitivity of flow cytometry

    Journal of Clinical Oncology, Vol. 27, Núm. 9, pp. 1462-1469

1987

  1. Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis.

    Thrombosis and haemostasis, Vol. 58, Núm. 2, pp. 753-757

  2. Assessment of Multimeric Structure and Ristocetin‐Induced Binding to Platelets of Von Willebrand Factor Present in Cryoprecipitate and Different Factor VIII Concentrates

    Vox Sanguinis, Vol. 52, Núm. 1-2, pp. 15-19

  3. Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals

    Blood, Vol. 70, Núm. 1, pp. 173-176

1986

  1. Platelet and plasma von willebrand factor: structural differences

    Thrombosis Research, Vol. 44, Núm. 1, pp. 125-128

1983

  1. ELECTROBLOTTING OF FACTOR VIII/VON WILLEBRAND FACTOR MULTIMERS AFTER ELECTROPHORESIS IN SDS–AGAROSE GEL, DISCONTINUOUS BUFFER SYSTEM

    British Journal of Haematology, Vol. 55, Núm. 1, pp. 195-196